Participant Perceptions in a Long-term Clinical Trial of Autosomal Dominant Polycystic Kidney Disease.
Amin S, Sangadi I, Allman-Farinelli M, Badve SV, Boudville N, Coolican H, Coulshed S, Foster S, Fernando M, Haloob I, Harris DCH, Hawley CM, Holt J, Howell M, Kumar K, Johnson DW, Lee VW, Mai J, Rangan A, Roger SD, Sud K, Torres V, Vilayur E, Rangan GK.
Amin S, et al. Among authors: harris dch.
Kidney Med. 2023 Jun 29;5(9):100691. doi: 10.1016/j.xkme.2023.100691. eCollection 2023 Sep.
Kidney Med. 2023.
PMID: 37602144
Free PMC article.
PLAIN-LANGUAGE SUMMARY: Advances in the clinical practice of autosomal dominant polycystic kidney disease (ADPKD) require affected individuals to voluntarily participate in long-term multicenter randomized controlled trials (RCTs). In this qualitative post hoc study of a 3 …
PLAIN-LANGUAGE SUMMARY: Advances in the clinical practice of autosomal dominant polycystic kidney disease (ADPKD) require affected individua …